MONTI, SARA
MONTI, SARA
DIPARTIMENTO DI MEDICINA INTERNA E TERAPIA MEDICA
20 years of experience with tumour necrosis factor inhibitors: what have we learned?
2018-01-01 Caporali, Roberto; Crepaldi, Gloria; Codullo, Veronica; Benaglio, Francesca; Monti, Sara; Todoerti, Monica; Montecucco, Carlomaurizio
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients
2023-01-01 Monti, Sara; Milanesi, Alessandra; Klersy, Catherine; Tomelleri, Alessandro; Dagna, Lorenzo; Campochiaro, Corrado; Farina, Nicola; Muratore, Francesco; Galli, Elena; Marvisi, Chiara; Bond, Milena; Berti, Alvise; Bortolotti, Roberto; Padoan, Roberto; Schiavon, Franco; Felicetti, Mara; Nannini, Carlotta; Cantini, Fabrizio; Giollo, Alessandro; Rossini, Maurizio; Conticini, Edoardo; Frediani, Bruno; Conti, Fabrizio; Priori, Roberta; Sebastiani, Marco; Cassone, Giulia; Quartuccio, Luca; Treppo, Elena; Bettio, Silvano; Hoxha, Ariela; Lovisotto, Marco; Emmi, Giacomo; Mattioli, Irene; Leccese, Pietro; Caporali, Roberto; Argolini, Lorenza Maria; Foti, Rosario; Visalli, Elisa; Colaci, Michele; Salvarani, Carlo; Montecucco, Carlomaurizio
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management
2019-01-01 Berti, Alvise; Caporali, Roberto; Montecucco, Carlomaurizio; Paolazzi, Giuseppe; Monti, Sara
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis
2021-01-01 Monti, Sara; Felicetti, Mara; Delvino, Paolo; Padoan, Roberto; Berti, Alvise; Paolazzi, Giuseppe; Brunori, Giuliano; Schiavon, Franco; Caporali, Roberto; Montecucco, Carlomaurizio
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes
2020-01-01 Monti, Sara; Craven, Anthea; Klersy, Catherine; Montecucco, Carlomaurizio; Caporali, Roberto; Watts, Richard; Merkel, Peter A; Luqmani, Raashid; Collaborators, On Behalf Of D C V A S
Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study
2023-01-01 Milanesi, Alessandra; Delvino, Paolo; Quaglini, Silvana; Montecucco, Carlomaurizio; Monti, Sara
Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners
2022-01-01 Iaccarino, Luca; Talarico, Rosaria; Bozzalla-Cassione, Emanuele; Burmester, Gerd R; Culver, Emma L; Doria, Andrea; Ebbo, Mikael; van Hagen, P Martin; Hachulla, Eric; van Laar, Jan A M; Lanzillotta, Marco; Martinez-Valle, Fernando; Montecucco, Carlomaurizio; Monti, Sara; Nalli, Cecilia; Schleinitz, Nicolas; Tincani, Angela; Della Torre, Emanuel; Alexander, Tobias
Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: Ͽ Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and SLE, hydroxychloroquine and no SLE patients with COVID-19: A comment' by Joob and Wiwanitkit
2020-01-01 Monti, S.; Montecucco, C.
Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak
2020-01-01 Monti, Sara; Montecucco, Carlomaurizio
Chronic pain: The burden of disease and treatment innovations
2015-01-01 Monti, Sara; Caporali, Roberto
Clinical course and outcome of COVID-19 in patients with rheumatic diseases: Are all biological disease-modifying antirheumatic drugs alike? Response to: Â € Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al
2020-01-01 Monti, S.; Montecucco, C.
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
2020-01-01 Monti, S.; Balduzzi, S.; Delvino, P.; Bellis, E.; Quadrelli, V. S.; Montecucco, C.
Clinical spectrum of anti-Jo-1-associated disease
2017-01-01 Monti, Sara; Montecucco, Carlomaurizio; Cavagna, Lorenzo
Cobalt hip prosthesis intoxication mimicking an autoimmune disease
2020-01-01 Biglia, A.; Morandi, V.; Monti, S.; Delvino, P.; Cavagna, L.; Montecucco, C.
Cobalt hip prosthesis intoxication mimicking an autoimmune disease
2021-01-01 Biglia, A.; Morandi, V.; Monti, S.; Delvino, P.; Cavagna, L.; Montecucco, C.
Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al
2020-01-01 Monti, Sara; Montecucco, Carlomaurizio
Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs'
2021-01-01 Bugatti, Serena; Balduzzi, Silvia; De Stefano, Ludovico; Manzo, Antonio; Xoxi, Blerina; Bogliolo, Laura; Monti, Sara; Delvino, Paolo; Montecucco, Carlomaurizio
Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis
2023-01-01 Bartoletti, Alice; Delvino, Paolo; Minetto, Marco; Milanesi, Alessandra; Bozzalla Cassione, Emanuele; Quadrelli, Verdiana Serena; Luinetti, Ombretta; Monti, Sara; Montecucco, Carlomaurizio
Development and implementation of the AIDA International Registry for patients with Behçet’s disease
2022-01-01 1, Antonio Vitale; 2, Francesca Della Casa; 3 4, Gaafar Ragab; A Almaghlouth 5 6, Ibrahim; 7, Giuseppe Lopalco; 8, Rosa Maria Pereira; 9, Silvana Guerriero; Govoni 10, Marcello; P Sfikakis 11, Petros; Giacomelli 12, Roberto; Ciccia 13, Francesco; Monti, Sara; Ruscitti 15, Piero; Piga 16, Matteo; Lomater 17, Claudia; Tufan 18, Abdurrahman; Opris-Belinski 19, Daniela; Emmi 20, Giacomo; Hernández-Rodríguez 21, José; Şahin 22, Ali; Domenico Sebastiani 23, Gian; Bartoloni 24, Elena; Akkoç 25, Nurullah; Soysal Gündüz 25, Özgül; Cattalini 26, Marco; Conti 27, Giovanni; Hatemi 28, Gulen; Maier 29, Armin; Parronchi 20, Paola; Del Giudice 30, Emanuela; Erten 31, Sukran; Insalaco 32, Antonella; Li Gobbi 33, Francesca; Cristina Maggio 34, Maria; Shahram 35, Farhad; 1, Valeria Caggiano; 3 4, Mohamed Tharwat Hegazy; 6, Kazi Nur Asfina; 7, Maria Morrone; L Prado 8, Leandro; 9, Rosanna Dammacco; Ruffilli 10, Francesca; Arida 11, Aikaterini; Navarini 12, Luca; Pantano 13, Ilenia; Cavagna, Lorenzo; Conforti 15, Alessandro; Cauli 16, Alberto; Maria Marucco 17, Elena; Kucuk 18, Hamit; Ionescu 19, Ruxandra; Mattioli 20, Irene; Espinosa 21, Gerard; Araújo 21, Olga; Karkaş 22, Burak; Canofari 23, Claudia; 1, Jurgen Sota; 3, Ahmed Hatem Laymouna; A Bedaiwi 5, Asma; 7, Sergio Colella; M Giardini 8, Henrique Ayres; 9, Valeria Albano; Lo Monaco 10, Andrea; E Fragoulis 11, George; Can Kardas 18, Riza; 1, Virginia Berlengiero; A Hussein 3, Mohamed; Ricci 26, Francesca; La Torre 36, Francesco; Rigante 37 38, Donato; Więsik-Szewczyk 39, Ewa; Frassi 40, Micol; Gentileschi 41, Stefano; Marco Tosi 42, Gian; 8, Marilia Ambiel Dagostin; 3, Ayman Abdel-Monem Ahmed Mahmoud; 1, Maria Tarsia; 9, Giovanni Alessio; Cimaz 43, Rolando; Giani 43, Teresa; 1, Carla Gaggiano; 7, Florenzo Iannone; Cipriani 15, Paola; 1, Mariam Mourabi; 7, Veronica Spedicato; 1, Sara Barneschi; Aragona 44, Emma; Balistreri 45, Alberto; Frediani 41, Bruno; # 42, Claudia Fabiani; Cantarini, Luca
Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: Lessons from a case with severe pneumonia' by Guilpain et al
2020-01-01 Monti, S.; Montecucco, C.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 20 years of experience with tumour necrosis factor inhibitors: what have we learned? | 1-gen-2018 | Caporali, Roberto; Crepaldi, Gloria; Codullo, Veronica; Benaglio, Francesca; Monti, Sara; Todoerti, Monica; Montecucco, Carlomaurizio | |
| Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients | 1-gen-2023 | Monti, Sara; Milanesi, Alessandra; Klersy, Catherine; Tomelleri, Alessandro; Dagna, Lorenzo; Campochiaro, Corrado; Farina, Nicola; Muratore, Francesco; Galli, Elena; Marvisi, Chiara; Bond, Milena; Berti, Alvise; Bortolotti, Roberto; Padoan, Roberto; Schiavon, Franco; Felicetti, Mara; Nannini, Carlotta; Cantini, Fabrizio; Giollo, Alessandro; Rossini, Maurizio; Conticini, Edoardo; Frediani, Bruno; Conti, Fabrizio; Priori, Roberta; Sebastiani, Marco; Cassone, Giulia; Quartuccio, Luca; Treppo, Elena; Bettio, Silvano; Hoxha, Ariela; Lovisotto, Marco; Emmi, Giacomo; Mattioli, Irene; Leccese, Pietro; Caporali, Roberto; Argolini, Lorenza Maria; Foti, Rosario; Visalli, Elisa; Colaci, Michele; Salvarani, Carlo; Montecucco, Carlomaurizio | |
| Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management | 1-gen-2019 | Berti, Alvise; Caporali, Roberto; Montecucco, Carlomaurizio; Paolazzi, Giuseppe; Monti, Sara | |
| Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis | 1-gen-2021 | Monti, Sara; Felicetti, Mara; Delvino, Paolo; Padoan, Roberto; Berti, Alvise; Paolazzi, Giuseppe; Brunori, Giuliano; Schiavon, Franco; Caporali, Roberto; Montecucco, Carlomaurizio | |
| Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes | 1-gen-2020 | Monti, Sara; Craven, Anthea; Klersy, Catherine; Montecucco, Carlomaurizio; Caporali, Roberto; Watts, Richard; Merkel, Peter A; Luqmani, Raashid; Collaborators, On Behalf Of D C V A S | |
| Azathioprine vs methotrexate in eosinophilic granulomatosis with polyangiitis: a monocentric retrospective study | 1-gen-2023 | Milanesi, Alessandra; Delvino, Paolo; Quaglini, Silvana; Montecucco, Carlomaurizio; Monti, Sara | |
| Blood biomarkers recommended for diagnosing and monitoring IgG4-related disease. Considerations from the ERN ReCONNET and collaborating partners | 1-gen-2022 | Iaccarino, Luca; Talarico, Rosaria; Bozzalla-Cassione, Emanuele; Burmester, Gerd R; Culver, Emma L; Doria, Andrea; Ebbo, Mikael; van Hagen, P Martin; Hachulla, Eric; van Laar, Jan A M; Lanzillotta, Marco; Martinez-Valle, Fernando; Montecucco, Carlomaurizio; Monti, Sara; Nalli, Cecilia; Schleinitz, Nicolas; Tincani, Angela; Della Torre, Emanuel; Alexander, Tobias | |
| Can hydroxychloroquine protect patients with rheumatic diseases from COVID-19? Response to: Ͽ Does hydroxychloroquine prevent the transmission of COVID-19?' by Heldwein and Calado and SLE, hydroxychloroquine and no SLE patients with COVID-19: A comment' by Joob and Wiwanitkit | 1-gen-2020 | Monti, S.; Montecucco, C. | |
| Candidate rheumatologic treatments for COVID-19. Response to: 'COVID-19 infection in a patient with FMF: does colchicine have a protective effect?' by Kobak | 1-gen-2020 | Monti, Sara; Montecucco, Carlomaurizio | |
| Chronic pain: The burden of disease and treatment innovations | 1-gen-2015 | Monti, Sara; Caporali, Roberto | |
| Clinical course and outcome of COVID-19 in patients with rheumatic diseases: Are all biological disease-modifying antirheumatic drugs alike? Response to: Â € Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab' by Schulze-Koops et al | 1-gen-2020 | Monti, S.; Montecucco, C. | |
| Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies | 1-gen-2020 | Monti, S.; Balduzzi, S.; Delvino, P.; Bellis, E.; Quadrelli, V. S.; Montecucco, C. | |
| Clinical spectrum of anti-Jo-1-associated disease | 1-gen-2017 | Monti, Sara; Montecucco, Carlomaurizio; Cavagna, Lorenzo | |
| Cobalt hip prosthesis intoxication mimicking an autoimmune disease | 1-gen-2020 | Biglia, A.; Morandi, V.; Monti, S.; Delvino, P.; Cavagna, L.; Montecucco, C. | |
| Cobalt hip prosthesis intoxication mimicking an autoimmune disease | 1-gen-2021 | Biglia, A.; Morandi, V.; Monti, S.; Delvino, P.; Cavagna, L.; Montecucco, C. | |
| Comorbidities and rheumatological diseases at the time of COVID-19. Response to: 'Rheumatic diseases in intensive care unit patients with COVID-19' by Moiseev et al | 1-gen-2020 | Monti, Sara; Montecucco, Carlomaurizio | |
| Correspondence on 'EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs' | 1-gen-2021 | Bugatti, Serena; Balduzzi, Silvia; De Stefano, Ludovico; Manzo, Antonio; Xoxi, Blerina; Bogliolo, Laura; Monti, Sara; Delvino, Paolo; Montecucco, Carlomaurizio | |
| Cytomegalovirus colitis unmasking human immunodeficiency virus infection as a cause of IgA vasculitis | 1-gen-2023 | Bartoletti, Alice; Delvino, Paolo; Minetto, Marco; Milanesi, Alessandra; Bozzalla Cassione, Emanuele; Quadrelli, Verdiana Serena; Luinetti, Ombretta; Monti, Sara; Montecucco, Carlomaurizio | |
| Development and implementation of the AIDA International Registry for patients with Behçet’s disease | 1-gen-2022 | 1, Antonio Vitale; 2, Francesca Della Casa; 3 4, Gaafar Ragab; A Almaghlouth 5 6, Ibrahim; 7, Giuseppe Lopalco; 8, Rosa Maria Pereira; 9, Silvana Guerriero; Govoni 10, Marcello; P Sfikakis 11, Petros; Giacomelli 12, Roberto; Ciccia 13, Francesco; Monti, Sara; Ruscitti 15, Piero; Piga 16, Matteo; Lomater 17, Claudia; Tufan 18, Abdurrahman; Opris-Belinski 19, Daniela; Emmi 20, Giacomo; Hernández-Rodríguez 21, José; Şahin 22, Ali; Domenico Sebastiani 23, Gian; Bartoloni 24, Elena; Akkoç 25, Nurullah; Soysal Gündüz 25, Özgül; Cattalini 26, Marco; Conti 27, Giovanni; Hatemi 28, Gulen; Maier 29, Armin; Parronchi 20, Paola; Del Giudice 30, Emanuela; Erten 31, Sukran; Insalaco 32, Antonella; Li Gobbi 33, Francesca; Cristina Maggio 34, Maria; Shahram 35, Farhad; 1, Valeria Caggiano; 3 4, Mohamed Tharwat Hegazy; 6, Kazi Nur Asfina; 7, Maria Morrone; L Prado 8, Leandro; 9, Rosanna Dammacco; Ruffilli 10, Francesca; Arida 11, Aikaterini; Navarini 12, Luca; Pantano 13, Ilenia; Cavagna, Lorenzo; Conforti 15, Alessandro; Cauli 16, Alberto; Maria Marucco 17, Elena; Kucuk 18, Hamit; Ionescu 19, Ruxandra; Mattioli 20, Irene; Espinosa 21, Gerard; Araújo 21, Olga; Karkaş 22, Burak; Canofari 23, Claudia; 1, Jurgen Sota; 3, Ahmed Hatem Laymouna; A Bedaiwi 5, Asma; 7, Sergio Colella; M Giardini 8, Henrique Ayres; 9, Valeria Albano; Lo Monaco 10, Andrea; E Fragoulis 11, George; Can Kardas 18, Riza; 1, Virginia Berlengiero; A Hussein 3, Mohamed; Ricci 26, Francesca; La Torre 36, Francesco; Rigante 37 38, Donato; Więsik-Szewczyk 39, Ewa; Frassi 40, Micol; Gentileschi 41, Stefano; Marco Tosi 42, Gian; 8, Marilia Ambiel Dagostin; 3, Ayman Abdel-Monem Ahmed Mahmoud; 1, Maria Tarsia; 9, Giovanni Alessio; Cimaz 43, Rolando; Giani 43, Teresa; 1, Carla Gaggiano; 7, Florenzo Iannone; Cipriani 15, Paola; 1, Mariam Mourabi; 7, Veronica Spedicato; 1, Sara Barneschi; Aragona 44, Emma; Balistreri 45, Alberto; Frediani 41, Bruno; # 42, Claudia Fabiani; Cantarini, Luca | |
| Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: Lessons from a case with severe pneumonia' by Guilpain et al | 1-gen-2020 | Monti, S.; Montecucco, C. |